RxDoctor Payments Data

Jamie Markulin

Gerontology · Merrillville, INNPI 1457096935

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 34 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 26.3% of the total.

$1,464in general payments, 2019–2025

Across 34 payments — averaging $43.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$385
  • Boston Scientific$380
  • Edwards Lifesciences$242
  • Amgen$142
  • Boehringer Ingelheim$93
  • Novartis$62
  • plus $160 from 5 others

What the payments were for

  • Food & beverage$1,464100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,464 in reported general payments places this provider in the 75th percentile of 230 gerontology providers in Indiana.

See all gerontology providers in Indiana

Medicare billing

Part B allowed, 2024
$13,053
Medicare patients
121
Services billed
177

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan15$15,490
Repatha SureclickEvolocumab16$12,376
EliquisApixaban13$10,815
ClopidogrelClopidogrel Bisulfate61$789
Metoprolol Succinate35$214
Atorvastatin Calcium25$153
Carvedilol12$88
Lisinopril13$56
Furosemide11$46
Amlodipine Besylate13$25
Ezetimibe15$23
Metformin Hcl15$10

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$62$15,49015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 230 gerontology providers in Indiana.

Other gerontology in Merrillville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →